Fonar (FONR) Competitors $15.80 +0.39 (+2.56%) As of 07/3/2025 01:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FONR vs. TMCI, NPCE, OM, CLPT, NNOX, ZIMV, SNWV, CATX, NYXH, and DRTSShould you be buying Fonar stock or one of its competitors? The main competitors of Fonar include Treace Medical Concepts (TMCI), NeuroPace (NPCE), Outset Medical (OM), ClearPoint Neuro (CLPT), Nano-X Imaging (NNOX), ZimVie (ZIMV), Sanuwave Health (SNWV), Perspective Therapeutics (CATX), Nyxoah (NYXH), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry. Fonar vs. Its Competitors Treace Medical Concepts NeuroPace Outset Medical ClearPoint Neuro Nano-X Imaging ZimVie Sanuwave Health Perspective Therapeutics Nyxoah Alpha Tau Medical Fonar (NASDAQ:FONR) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability, media sentiment and institutional ownership. Do analysts recommend FONR or TMCI? Treace Medical Concepts has a consensus target price of $10.16, suggesting a potential upside of 67.86%. Given Treace Medical Concepts' stronger consensus rating and higher possible upside, analysts clearly believe Treace Medical Concepts is more favorable than Fonar.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fonar 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Treace Medical Concepts 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29 Does the media prefer FONR or TMCI? In the previous week, Fonar and Fonar both had 1 articles in the media. Treace Medical Concepts' average media sentiment score of 1.84 beat Fonar's score of 0.00 indicating that Treace Medical Concepts is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fonar 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has more risk and volatility, FONR or TMCI? Fonar has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.Comparatively, Treace Medical Concepts has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Is FONR or TMCI more profitable? Fonar has a net margin of 8.19% compared to Treace Medical Concepts' net margin of -25.14%. Fonar's return on equity of 5.31% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets Fonar8.19% 5.31% 3.97% Treace Medical Concepts -25.14%-48.69%-24.59% Do insiders and institutionals hold more shares of FONR or TMCI? 50.6% of Fonar shares are owned by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are owned by institutional investors. 1.6% of Fonar shares are owned by company insiders. Comparatively, 27.7% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has stronger valuation and earnings, FONR or TMCI? Fonar has higher earnings, but lower revenue than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Fonar, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFonar$103.02M0.95$10.57M$1.2512.64Treace Medical Concepts$210.82M1.81-$55.74M-$0.85-7.12 SummaryTreace Medical Concepts beats Fonar on 8 of the 15 factors compared between the two stocks. Get Fonar News Delivered to You Automatically Sign up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FONR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FONR vs. The Competition Export to ExcelMetricFonarMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$98.03M$10.19B$5.49B$9.02BDividend YieldN/A2.09%5.38%4.10%P/E Ratio12.6416.7427.4720.28Price / Sales0.9529.14408.86121.46Price / Cash5.0122.8436.6357.47Price / Book0.643.668.095.68Net Income$10.57M$235.40M$3.17B$248.96M7 Day Performance6.21%2.15%2.81%3.30%1 Month Performance9.37%3.00%3.67%5.20%1 Year Performance-1.56%-10.21%35.41%21.37% Fonar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FONRFonar0.8116 of 5 stars$15.80+2.6%N/A-1.6%$98.03M$103.02M12.64480Positive NewsTMCITreace Medical Concepts2.6848 of 5 stars$5.88+2.3%$10.16+72.7%-8.5%$361.62M$209.36M-6.92250Positive NewsNPCENeuroPace2.9685 of 5 stars$11.14+4.0%$15.50+39.1%+41.2%$351.27M$79.91M-13.26170High Trading VolumeOMOutset Medical1.6832 of 5 stars$19.21+0.7%$27.00+40.6%-63.9%$337.96M$113.69M-0.66520High Trading VolumeCLPTClearPoint Neuro2.4093 of 5 stars$11.94+1.2%$25.00+109.4%+120.7%$330.27M$31.39M-15.71110Positive NewsHigh Trading VolumeNNOXNano-X Imaging1.5117 of 5 stars$5.17-1.1%$9.50+83.8%-25.3%$302.18M$11.28M-5.74190ZIMVZimVie2.3543 of 5 stars$9.35+1.0%$16.33+74.7%-44.8%$257.87M$449.75M-13.171,770SNWVSanuwave HealthN/A$32.86+9.7%N/AN/A$256.24M$32.63M-7.2140CATXPerspective Therapeutics1.9234 of 5 stars$3.44-8.5%$12.56+265.0%-66.5%$255.34MN/A0.0070NYXHNyxoah2.4891 of 5 stars$7.48+0.1%$14.50+93.9%+5.1%$254.43M$4.89M-3.51110Positive NewsGap UpDRTSAlpha Tau Medical2.5476 of 5 stars$3.12+4.7%$8.00+156.4%+42.2%$252.76MN/A-6.7880News Coverage Related Companies and Tools Related Companies Treace Medical Concepts Competitors NeuroPace Competitors Outset Medical Competitors ClearPoint Neuro Competitors Nano-X Imaging Competitors ZimVie Competitors Sanuwave Health Competitors Perspective Therapeutics Competitors Nyxoah Competitors Alpha Tau Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FONR) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fonar Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Fonar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FONR Stock Alerts